Methodology
robust evidence
4 min · 4 sources
Published Jun 26, 2026

Allocation Concealment

Keeps the next trial group hidden from the person enrolling participants

If this step is weak, the trial groups can be tilted before treatment starts, and the result can look more trustworthy than it is.

Also known as concealed allocation · allocation sequence concealment · treatment allocation concealment · concealment of randomization · central randomization

Randomization creates the assignment order, and allocation concealment keeps that order hidden until enrollment is locked in.¹
Concealment prevents selection bias, where enrolled groups differ before treatment begins.⁴
Double blinding does not replace allocation concealment because blinding protects a later stage of the trial.²

The moment a trial can be biased before it starts

A trial can use a random number list and still be unfair. That is the specific catch behind allocation concealment. Randomization answers one question: what order should assignments follow? Allocation concealment answers a different question: can the recruiter see or guess the next assignment before deciding who gets in?

That timing matters. The bias happens before the participant is assigned. If a clinic worker knows the next person will receive a probiotic, creatine, placebo, or usual care, that knowledge can change who gets enrolled at that moment. A borderline participant may be included, delayed, or skipped. The change may be subtle and even well intentioned, but it can tilt the groups.

The surprise: blinding is too late to fix this

Many readers look for the phrase “double blind” and assume the trial is protected. Double blinding usually means people do not know which treatment someone received after assignment. Allocation concealment protects the step before assignment. These are different doors in the trial process.

A trial can be blinded but poorly concealed if the assignment list was visible, predictable, or kept in envelopes that could be opened early. A trial can also have good allocation concealment even if later blinding is impossible, such as a diet or exercise study. The Cochrane risk of bias guidance treats failures in this area as part of bias from the randomization process, because the problem is unequal starting groups, not expectation after treatment begins.

Good concealment uses practical barriers. Examples include a secure central randomization service, a pharmacy that releases the next coded bottle only after enrollment, or sequentially numbered, opaque, sealed envelopes prepared so they cannot be read or rearranged. CONSORT, the reporting standard for randomized trials, asks authors to report the mechanism used to implement the random sequence and the steps taken to keep it hidden until assignment.

Why reviewers care so much

This is not a paperwork preference. A major JAMA study found that trials with inadequate allocation concealment reported larger treatment effects than trials with adequate concealment. In that analysis, odds ratios were exaggerated by 41 percent when concealment was inadequate and by 30 percent when it was unclear. Later Cochrane work found that the size and direction of bias are hard to predict, but inadequate or unclear concealment remains a serious warning sign.

The word “unclear” is important. If a paper says “participants were randomized” but never explains how the next assignment was hidden, a careful reader should not give it full credit. Randomized is not the same as protected.

The one decision to make today

When you read a supplement trial, find the randomization section and look for the sentence that explains concealment. If it only says “randomized” or “computer generated,” treat the trial as less reliable than a trial that names a real concealment method, such as central randomization, pharmacy controlled assignment, or properly prepared sealed opaque envelopes. That single sentence can change how much trust the result deserves.

When you'll see this

The term in the wild

You are reading a creatine trial that says, “Participants were randomized using a computer generated list,” but gives no other detail.

The computer list may be truly random, but the paper has not told you whether recruiters could see or guess the next assignment.

The result may still be useful, but you should downgrade your confidence because the starting groups may have been shaped by human choices.
A probiotic capsule study says bottles were numbered by an independent pharmacy, and researchers assigned the next bottle only after a participant signed consent.

That is a strong recognition cue. The person enrolling participants did not control or know the next assignment.

You can put more trust in the group comparison because the trial protected the decision point where selection bias can enter.
In a systematic review, one vitamin D trial is labeled “high risk of bias from the randomization process.”

That label may mean the reviewers saw a problem with how assignments were generated, concealed, or balanced at baseline.

A positive result from that trial should carry less weight than a similar result from a trial with low risk of bias.

Myths vs reality

What people get wrong

Myth

“Randomized” automatically means allocation was concealed.

Why people believe it The word “randomized” appears in titles and abstracts, while CONSORT item 9 asks for a separate allocation concealment mechanism that is often buried in the methods section.

Reality

Randomized only says there was an assignment order. Concealed means the next assignment was hidden from the person enrolling participants.
Myth

Double blinding solves the allocation concealment problem.

Why people believe it Trial reports often highlight blinding because it is easier for readers to recognize, while the enrollment step is less visible.

Reality

Blinding usually starts after assignment. Allocation concealment protects the earlier moment when a person is accepted into the trial.
Myth

Sealed envelopes are always adequate concealment.

Why people believe it Authors may write “sealed envelopes” without describing the safeguards that make envelopes trustworthy.

Reality

Envelopes only work if they are opaque, sealed, sequentially numbered, and opened in order after enrollment. Weak envelopes can be peeked through, opened early, or rearranged.

For supplement evidence, the specific failure mode to avoid is treating “computer randomized” as enough. A computer can create a fair list, but a visible fair list can still be misused during enrollment.

Frequently asked

Common questions

Where should I look for allocation concealment in a paper?

Look in the methods section under randomization, sequence generation, or trial procedures. The key sentence should explain who held the assignment list and how the next assignment stayed hidden until enrollment.

What is a strong allocation concealment method in a supplement trial?

A strong method is one the recruiter cannot override, such as central randomization or numbered bottles prepared by an independent pharmacy after the random sequence is created.

What should I think when allocation concealment is not reported?

Treat it as unclear risk, not proof of fraud. The trial may have been done well, but the paper has not shown you the protection that matters.

Can allocation concealment matter in small pilot studies?

Yes. Small studies are especially easy to tilt because moving only a few higher risk or lower risk participants into one group can change the result.

Sources